Few ill health situations are more degrading to people of any age than loss of reasoning, faculties, and personhood. These are the unpleasant consequences of delirium-a common condition affecting ill older people, particularly those with some degree of dementia. It is characterised by recent onset of fluctuating inattention and confusion, linked to one or more triggering factors.
Delirium is a major burden to healthcare services and has been largely ignored by health service planners and practitioners.
1 Moreover, healthcare systems and services often unintentionally stimulate or substantially aggravate the development of delirium in older people. 2 This might be understandable if delirium was unavoidable or untreatable, but the existing evidence base for delirium is sufficiently robust for prevention or attenuation of the condition to be a realistic proposition. There is a pressing need to take this action because the outcomes for delirium are poor: it contributes to substantial morbidity and mortality, causes considerable distress to patients and families, and is expensive-an estimated additional $2500 (£1275; €1875) per patient (a $6.9bn annual expenditure for Medicare in 2004). 3 
Sources and selection criteria
We searched Medline and the Cochrane Library from 1996 to 2006. We drew additional material from our personal libraries of delirium references, focusing particularly on systematic reviews.
How common is delirium?
Delirium is an important problem for all clinical services providing care for older people, particularly emergency departments; general medical, elderly care, surgical, and oncology wards; intensive care units; and, in the community, residential and nursing homes. Delirium is the most common complication of hospital admission for older people.
w1 It develops in up to a half of older patients postoperatively; especially after hip fracture and vascular surgery.
w2 w3 A systematic review that identified 42 studies of occurrence and outcomes of delirium in medical inpatients found that the occurrence of delirium varied between 11% and 42%. 4 These rates are likely to be underestimates, resulting from bias in study recruitment, which favours people without dementia (therefore with a lower risk of delirium). 5 What are the consequences of delirium? Estimates for outcomes for delirium are influenced by elements of study design such as case ascertainment, confounder adjustment, and adequacy of follow-up.
w4
A well conducted, prospective comparison study of medical patients with delirium reported a twofold increase in discharge mortality, an average increase of eight days in the length of stay in hospital, and worse physical and cognitive recovery at six and 12 months with increased time in institutional care. 6 Good evidence also exists that symptoms of delirium persist in about a third of patients 4 and that these patients have a worse prognosis. 7 After recovery from delirium, patients can experience recollections of the event that they find unpleasant and disturbing.
w5
What are the clinical features of delirium? The cardinal features of delirium are recent onset of fluctuating awareness, impairment of memory and attention, and disorganised thinking (box 1). 8 Additional features may include hallucinations and disturbance of the sleep-wake cycle. There are three clinical subtypes of delirium: hyperactive, hypoactive, and mixed (boxes 2 and 3). Hypoactive delirium is less likely to be recognised despite patients having a more severe illness. 9 The term subsyndromal delirium has been suggested for patients who have an incomplete form of delirium. How is delirium diagnosed? The diagnosis of delirium rests solely on clinical skills; no diagnostic test exists. This may partly explain why it is undiagnosed in over a half of patients with the condition.
w7 w8 Delayed or missed diagnosis is an important issue-non-detection of delirium in emergency departments is associated with a sevenfold hazard for increased mortality.
w9 Healthcare professionals often describe a patient with possible delirium as "confused elderly patient," but this fails to distinguish between delirium and dementia. Obtaining the history of the clinical course of any cognitive changes from a family member or carer is key to recognising delirium. A diagnosis of delirium will stimulate the appropriate, probing clinical questions: what has happened to the patient; what are the underlying factors; how can they be resolved; and could the delirium have been prevented? A core feature of delirium is its impact on cognitive function. Guidelines therefore recommend that all clinical encounters with sick older people should routinely include assessment of cognition. 10 11 The minimental state examination (30 questions) w10 and the abbreviated mental test (10 questions) w11 are widely used in routine care, but full completion is often difficult in an acute setting in patients who are ill or in pain. The cognitive impairment test (six questions) w12 and the four item abbreviated mental test score w13 correlate well with the mini-mental state examination and are simple to administer. Alternatively, quick screening instruments for inattention include the digit span test and listing days of the week backwards. Sequential cognitive assessments-for example, using the minimental state examination daily-can successfully monitor development and resolution of delirium. 12 Several diagnostic instruments have been developed for detecting delirium. US and UK guidelines recommend the confusion assessment method for routine use. 10 11 13 The shorter form has four questions (box 4); it performs as well as the more complex delirium rating scale w14 and can be completed in less than five minutes.
w15 Appropriate training and use of a brief cognitive assessment instrument 14 results in a sensitivity and specificity of over 90%. 13 The overlap between delirium and dementia Distinguishing delirium from dementia is a common clinical dilemma. There is a strong inter-relationship between delirium and dementia, both pathophysiologically w16 and clinically. 15 Dementia is associated with an increased risk of developing delirium, and delirium is associated with increased risk of developing dementia, although it is unclear whether the delirium is unmasking previously unrecognised dementia or initiating a process of cognitive decline. 15 It can be particularly difficult to distinguish delirium from Lewy body dementia because some features, such as hallucinations and symptom fluctuation, are common to both. The safest clinical approach is to consider that all older people presenting with confusion have delirium until proved otherwise (table 1) . This implies completion of the cognitive assessments described above, obtaining an adequate history of the course of cognitive changes, and a thorough search for delirium recipitants.
What are the causes of delirium? The pathophysiology of delirium is poorly understood; various concepts have been reviewed.
w17-w19
Good evidence suggests neurotransmitter disturbances, especially acetylcholine deficiency and dopamine excess. Less well supported mechanisms are illness related stress with overactivity of the hypothalamic-pituitary-adrenal axis, and the effects of increased cytokine production on cerebral function. A recent finding has been reduced activity of plasma esterases in delirium w20 ; these are important drug metabolising enzymes and may partly explain why drugs are common precipitants for delirium. A unifying approach is to regard delirium as a clinical syndrome resulting from an interconnection of several pathological mechanisms.
w17 w19
The concept of patient vulnerability (risk factors) in relation to stressor events (precipitants that trigger an episode of delirium) has proved a practical approach to understanding delirium. 16 In most older patients, several precipitants may exist. The precipitants do not alone cause delirium; they interact with the underlying risk factors. Thus, a major insult, such as a serious infection, is required to trigger delirium in a previously fit person, but even a minor perturbation (such as a change in medication) can result in delirium in a person with many risk factors. Older people with multiple chronic diseases are therefore especially prone to delirium.
In older people the precipitants may present in occult or atypical fashion, confounding even experienced clinicians. Thus, a careful search for occult infection, myocardial infarction, metabolic disorders, or respiratory failure may be necessary. Systematic reviews have assessed studies investigating risk factors in medical and surgical patients.
w21-w23
Box 2 | Hyperactive delirium Scenario An elderly woman has been admitted to your ward having been found lying on the floor by the home care staff. She seems to be talking to herself, sometimes loudly, but it is hard to understand what she is saying. She has a rather anxious demeanour and repeatedly pulls at her bedclothes. She argues with the nursing staff and has angrily refused to have a blood sample taken. Features In hyperactive delirium a patient has heightened arousal and can be very sensitive to his or her immediate surroundings, such that they can be verbally and physically threatening and aggressive. They can be restless, sometimes pulling repeatedly at clothing (called carphologia), and wandering is a common feature. • History, physical examination, and laboratory findings show that delirium can be a physiological consequence of general condition; caused by intoxication; caused by medication; and caused by more than one aetiology The reviews are limited by variation in quality and heterogeneity of the constituent studies. The commonly encountered risk factors and precipitants for delirium are listed in box 5. Environmental risk factors for delirium include moves within the hospital, absence of a clock or watch, absence of reading glasses, presence of a family member, and use of restraints (physical or drugs). 2 Understanding the risk factors for delirium provides an important opportunity to identify patients at high risk of developing the condition using predictive models 16 w24-w26 and to target these patients for preventive interventions. Pre-existing dementia is common to all the predictive models and is the dominant risk factor associated with development of delirium.
Drugs and delirium
Drugs are an important risk factor and precipitant for delirium in older people: medications may be the sole precipitant for 12%-39% of cases of delirium. 17 The most common drugs associated with delirium are psychoactive agents such as benzodiazepines, narcotic analgesics such as morphine, and drugs with anticholinergic effects. Many commonly used drugs in Box 4 | Confusion assessment method* 13 14 The diagnosis of delirium requires a present or abnormal rating for criteria 1 and 2 plus either 3 or 4. 
Patient 1 (dementia)
A 78 year old woman is found by her neighbours confused and wandering in the street at night wearing her night clothes. In the emergency room she appears unkempt and dishevelled. She is alert, but disoriented in time and place and cannot recall her home address. She engages well with questions, but tends to shift the conversation to stories about her husband and children. She is admitted to hospital and wanders around the ward appearing lost and, when asked, says that she is looking for a bus stop to go home
All the clinical observations suggest that she does not have delirium. She is alert (no clouding of consciousness), engages well in conversation (no attention impairment). Although she has apparent night-time restlessness (altered sleep-wake cycle), this is explained by her search for a bus stop. The critical clinical action needed is to contact an informant who knows her. How long has she been confused? If she has a dementia, her family, neighbours, community support staff, or primary care team will know when she was last well and the duration of her confusional state
Patient 2 (delirium)
An 89 year old woman living alone is brought to your clinic by her daughter. The daughter explains that dementia was diagnosed at the local memory clinic about five years ago. Her mother has gradually deteriorated but has been coping at home with home care support. Two days ago she became incontinent of urine (unusual for her) and more confused in her conversation with the home care team, who also found her rather sleepy
As this patient has dementia, she will be at especially high risk of delirium episodes. Features of delirium can be seen in this patient: short history of deterioration, disorganised conversation with the home care staff (who will know her usual abilities well), and observed sleepiness. The recent onset of urinary incontinence suggests that the delirium precipitant may be a urinaryinfection
Box 3 | Hypoactive delirium Scenario
An elderly man is recovering from a heart attack and seems to want to lie in bed. He is polite when approached, but sleepy, and he doesn't seem interested in eating or drinking. Sometimes his speech is incoherent and he doesn't seem to follow what is said to him.
Features
The clinical clues for delirium in this patient are much less obvious than in a patient with hyperactive delirium (box 2), although he displays all the major features of delirium. Hypoactive delirium is the more common of the two subtypes, but careful bedside observation skills are required to detect its more subtle features. This is one important reason why delirium is easily overlooked.
older people have anticholinergic effects, 18 although these effects may not be well known (table 2) . Whenever possible, these drugs should be discontinued in patients who are at risk of or have developed delirium.
Can delirium be prevented? Most evidence for delirium prevention that informs clinical practice is from non-randomised clinical studies (although a Cochrane review of randomised controlled trials is in press 19 ). These studies 20 w27-w31 and one randomised controlled trial 21 collectively indicate that the most successful approach to delirium prevention is to attenuate modifiable risk factors in individual patients. This requires a complex intervention, and studies investigating such interventions in medical patients and those who have had hip fracture have reported significant reductions (of about a third) in incidence of delirium and/or reduced severity and duration of delirium. 20 21 w27-w31 In contrast, the dissemination of good practice guidelines on delirium alone was only weakly effective w32 probably because the guidelines were not practical enough for the complexity of delirium so were not adhered to. Indeed, sustained adherence to the clinical protocol is a key factor for successful delirium prevention. 22 The effective Yale delirium prevention model of care 19 has been translated into routine practice as the hospital elder life program (HELP). 23 This programme is now used in three countries and is associated with a reduction in the rates and costs of delirium.
w33
Effective strategies for delirium prevention include orienting communication, therapeutic activities, early mobilisation and walking, non-pharmacological approaches to sleep and anxiety, maintaining nutrition and hydration, adaptive equipment for vision and hearing impairment, and pain management. Hospitals have several inherent risks for the development of delirium 2 and early discharge to a home rehabilitation service was associated with a significantly reduced incidence of delirium. 24 How can delirium be managed? Immediate identification and treatment of precipitants (box 5), withdrawal of drugs (table 2) , and supportive care (including management of hypoxia, hydration and nutrition, minimising the time spent lying in bed, and mobilisation) are the critical actions required. Three randomised controlled trials showed that input from a specialist, protocol based multidisciplinary team was no better than usual ward care.
w34 w35
Some hospitals have delirium units, but these have not been robustly evaluated.
w36 For patients with hyperactive delirium, physical restraints should be avoided because they tend to increase agitation and injury.
w37 Drug treatment should be reserved for patients who pose a risk to themselves or others, as the treatments may prolong or aggravate delirium in some cases.
A systematic review of psychotropic medication in delirium showed the paucity of reliable information available (four heterogeneous studies involving only 174 patients) but recommended low dose haloperidol as the best studied agent. w38 The atypical antipsychotic drugs risperidone and olanzapine should be avoided in patients with dementia complicated by delirium because of the associated increased risk of stroke. w39 w40
Conclusions
Delirium is a major healthcare concern in countries with ageing populations. It is associated with poor 
